| Tbio | Calcipressin-3 |
Inhibits calcineurin-dependent transcriptional responses by binding to the catalytic domain of calcineurin A. Could play a role during central nervous system development (By similarity).
Comments
| Disease | Target Count | P-value |
|---|---|---|
| lung carcinoma | 2843 | 5.8e-19 |
| posterior fossa group A ependymoma | 468 | 3.3e-08 |
| malignant mesothelioma | 3232 | 8.3e-08 |
| sarcoidosis | 370 | 8.6e-06 |
| cystic fibrosis | 1696 | 1.1e-04 |
| group 4 medulloblastoma | 1855 | 6.1e-04 |
| lung cancer | 4740 | 8.9e-04 |
| ovarian cancer | 8520 | 2.9e-03 |
| astrocytic glioma | 2597 | 7.9e-03 |
| subependymal giant cell astrocytoma | 2287 | 1.1e-02 |
| invasive ductal carcinoma | 2951 | 1.4e-02 |
| Astrocytoma, Pilocytic | 3081 | 1.4e-02 |
| Breast cancer | 3578 | 2.3e-02 |
| pediatric high grade glioma | 1064 | 2.6e-02 |
| acute myeloid leukemia | 783 | 3.7e-02 |
| progressive supranuclear palsy | 676 | 3.7e-02 |
| Disease | Target Count | Z-score | Confidence |
|---|---|---|---|
| Down syndrome | 499 | 3.729 | 1.9 |
| Disease | log2 FC | p |
|---|---|---|
| acute myeloid leukemia | 1.500 | 3.7e-02 |
| astrocytic glioma | -2.500 | 7.9e-03 |
| Astrocytoma, Pilocytic | -1.300 | 1.4e-02 |
| Breast cancer | 3.000 | 2.3e-02 |
| cystic fibrosis | 1.093 | 1.1e-04 |
| group 4 medulloblastoma | 2.300 | 6.1e-04 |
| invasive ductal carcinoma | 1.200 | 1.4e-02 |
| lung cancer | 1.300 | 8.9e-04 |
| lung carcinoma | 1.500 | 5.8e-19 |
| malignant mesothelioma | -2.700 | 8.3e-08 |
| ovarian cancer | 1.300 | 2.9e-03 |
| pediatric high grade glioma | -1.300 | 2.6e-02 |
| posterior fossa group A ependymoma | 1.200 | 3.3e-08 |
| progressive supranuclear palsy | -1.100 | 3.7e-02 |
| sarcoidosis | -1.300 | 8.6e-06 |
| subependymal giant cell astrocytoma | -3.596 | 1.1e-02 |
